Skip to main content
Immutep Limited (ASX:IMM)
Australia flag Australia · Delayed Price · Currency is AUD
0.395
+0.015 (3.95%)
At close: Mar 6, 2026

Immutep Revenue

Immutep had revenue of 6.03M AUD in the half year ending December 31, 2025, with 185.52% growth. This brings the company's revenue in the last twelve months to 7.92M, up 62.39% year-over-year. In the fiscal year ending June 30, 2025, Immutep had annual revenue of 5.04M with 31.28% growth.

Revenue (ttm)
7.92M
Revenue Growth
+62.39%
P/S Ratio
73.47
Revenue / Employee
255.57K
Employees
31
Market Cap
582.12M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20255.04M1.20M31.28%
Jun 30, 20243.84M336.16K9.59%
Jun 30, 20233.51M-1.21M-25.64%
Jun 30, 20224.71M851.56K22.04%
Jun 30, 20213.86M-9.88M-71.88%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Clinuvel Pharmaceuticals 96.30M
Opthea -20.12K
Racura Oncology 3.48M
Clarity Pharmaceuticals 10.58M
Dimerix 7.42M
Orthocell 9.33M
PYC Therapeutics 20.56M
Neuren Pharmaceuticals 64.65M
Revenue Rankings

Immutep News

More News